BRIEFLY.
Bath University Launches GlucoBrain Project to Study Diabetes-Brain Link with Organ-on-a-Chip
•
1 min read
•
Briefly Editorial Team

Bath University Launches GlucoBrain Project to Study Diabetes-Brain Link with Organ-on-a-Chip

TL;DR

  • •GlucoBrain project funded with £500,000 from UK research council.
  • •Organ-on-a-chip technology replicates real-time organ communication.
  • •Research could lead to personalized medicine and drug testing without animals.

Why it matters

Diabetes and dementia are global health crises. Current methods using animal models or 2D cell cultures fail to capture complex human physiology. This technology enables precise, ethical research on human tissues.

Project Goals

The University of Bath leads the GlucoBrain initiative, creating an organ-on-a-chip system to study diabetes-related cognitive decline. The project, funded by the UK Engineering and Physical Sciences Research Council, involves Oxford and Johns Hopkins universities.

Organ-on-a-Chip Technology

The system uses human cells in microfluidic devices to simulate blood flow and three-dimensional cell interactions. This allows real-time monitoring of signals between organs, which traditional methods cannot achieve.

Medical Implications

The research will clarify how diabetes impacts brain function and accelerate drug development. Future applications include personalized medicine, where doctors can test therapies on patient-derived cells without risking human health.